Selfcare, Inc.'s OTC electrochemical blood glucose monitor to be marketed by LifeScan.
This article was originally published in The Tan Sheet
Executive Summary
SELFCARE'S OTC ELECTROCHEMICAL BLOOD GLUCOSE MONITOR KIT PENDING AT FDA; the company filed a 510k application in late May. The test kit will be marketed by Johnson & Johnson subsidiary LifeScan under a November 1995 worldwide alliance with Waltham, Mass-based Selfcare. LifeScan, the leader in the OTC blood glucose test market, does not currently market an electrochemical test. Plans for the product were disclosed by Selfcare in a preliminary prospectus for an initial public offering.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning